Viridian Therapeutics, Inc./DE
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $203.7M
Liabilities Breakdown FY2021
Total Liabilities: $16.0M
Asset Breakdown
Total Assets: $203.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $42.3M | 20.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $375.0K | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $161.0M | 79.1% |
Liabilities Breakdown
Total Liabilities: $16.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.3M | 14.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $13.7M | 85.4% |